...
首页> 外文期刊>Journal of Clinical Microbiology >Transmission of Drug-Resistant Tuberculosis in Texas and Mexico
【24h】

Transmission of Drug-Resistant Tuberculosis in Texas and Mexico

机译:德克萨斯州和墨西哥的耐药结核病传播

获取原文
           

摘要

To examine the transmission of drug-resistant (DR) tuberculosis between Texas and Mexico, Mycobacterium tuberculosis isolates resistant to one or more of the first-line antimycobacterial drugs were obtained from 606 patients who resided in Texas and 313 patients who resided in Mexico, primarily within the state of Tamaulipas. The isolates were genotyped by IS6110-based restriction fragment length polymorphism (RFLP) analysis and spoligotyping. Of the 919 isolates genotyped, 413 (45%) grouped into 105 clusters containing 2 or more isolates with identical genotypes. In addition to having identical genotypes, identical drug resistance patterns were identified in 250 isolates in 78 clusters (DR clusters). Twenty DR clusters, containing isolates from 32% of the total number of patients infected with DR strains, were geographically distributed across Mexico and Texas. Within this population of 919 patients infected with DR isolates, the probability of being in a DR cluster was the same for residents of Mexico and Texas. In Texas, the significant independent predictors of clustering within DR clusters as opposed to genotype clusters were found to be race, age, country of birth, human immunodeficiency virus (HIV) infection status, and resistance to more than one drug. Specifically, isolates from African Americans, individuals under age 65, individuals born in the United States, and HIV-positive individuals were each more likely to be associated with a DR cluster. By contrast, no significant independent predictors of clustering in a DR cluster were identified in Mexico. Although some DR M. tuberculosis strains are geographically restricted, this study suggests that a number of strains are transmitted between Mexico and the United States.
机译:为了研究得克萨斯州和墨西哥之间耐药性(DR)结核病的传播,从得克萨斯州的606名患者和313名患者中获得了对一种或多种一线抗分枝杆菌药物有抗药性的结核分枝杆菌在墨西哥居住的患者,主要在塔毛利帕斯州内。通过基于IS 6110 的限制性酶切片段长度多态性(RFLP)分析和Spoligotyping基因分型。在919个基因型分离株中,有413个(45%)分为105个簇,其中包含2个或更多具有相同基因型的分离株。除了具有相同的基因型外,在78个聚类(DR聚类)的250个分离物中鉴定出相同的耐药模式。在墨西哥和德克萨斯州,分布了二十个DR簇,其中包含来自感染DR菌株的患者总数的32%的分离株。在这919名感染DR分离株的患者中,墨西哥和德克萨斯州居民出现DR簇的可能性相同。在德克萨斯州,发现与基因型群集相反,DR群集中群集的重要独立预测因素是种族,年龄,出生国家,人类免疫缺陷病毒(HIV)感染状况以及对多种药物的耐药性。具体而言,从非洲裔美国人,65岁以下的个体,在美国出生的个体和HIV阳性个体的分离株更可能与DR群相关。相比之下,墨西哥没有发现DR群集中群集的重要独立预测因子。虽然有些DR M。结核菌株在地理上受到限制,这项研究表明,许多菌株在墨西哥和美国之间传播。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号